Idera Pharmaceuticals Inc (IDRA)

NASDAQ
0.6645
+0.0257(+4.02%)
  • Volume:
    271,405
  • Day's Range:
    0.6275 - 0.6799
  • 52 wk Range:
    0.2950 - 1.7050

IDRA Overview

Prev. Close
0.6388
Day's Range
0.6275-0.6799
Revenue
-
Open
0.65
52 wk Range
0.295-1.705
EPS
-0.44
Volume
271,405
Market Cap
36.01M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,025,091
P/E Ratio
-
Beta
1.34
1-Year Change
-41.39%
Shares Outstanding
52,966,025
Next Earnings Date
Aug 08, 2022
What is your sentiment on Idera Pharma?
or
Vote to see community's results!

Idera Pharmaceuticals Inc News

Idera Pharmaceuticals Inc Analysis

Idera Pharmaceuticals Inc Company Profile

Idera Pharmaceuticals Inc Company Profile

Employees
13

Idera Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the clinical development, and commercialization of drug candidates for rare diseases and oncology. The Company designed and is developing tilsotolimod, an investigational Toll-like receptor 9 agonist, for the treatment of advanced solid tumors. Its lead investigational product, tilsotolimod, demonstrated activity in various pre-clinical models and is in clinical development across several oncology indications. These indications include anti-PD-1 refractory advanced melanoma, microsatellite-stable colorectal cancer (MSS-CRC, phase II), and recurrent/metastatic head & neck squamous cell carcinoma (HNSCC, phase I/II). Tilsotolimod is used for the treatment of anti-PD-1 refractory melanoma, in combination with ipilimumab, as well as for the treatment of stage IIb-IV melanoma. Its clinical trials include ILLUMINATE-204, ILLUMINATE-206 and ILLUMINATE-101.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • If it stays under $1, will it be listed on otc?
    0
    • Yes
      0
  • oh my god
    0
    • oh my god we're all gonna die!
      0
      • Idra never die
        0
      • w
        0
    • Why this stock is not soaring they decreased their debt to a very low level and they have a huge cashflow
      0
      • $3 very soon 🚀🚀🚀
        2
        • Why?
          0
        • Because God is investitor
          0
      • yeah guessing this is a going concern issue....massive liabilities and current ratio so if they don't get that under control this is done....is this sort of business model and massive insane debt common in these pharma companies?
        2
        • will sound very boring but the good old STOP LOSS seems like a good idea here...
          0
          • What on earth is going with this......Very odd....and there really still are shorts on this??? crazy.....I guess greed knows no bounds on either side....adding more to my $2 calls...will bounce back hard
            0
            • Short covered. 4mill short now.
              0
              • going to 0
                0
                • Call me Caitlyn  hertz was down to first 0.50 so this goign near 0. get out
                  0
                • Like I said....there will be a short squeeze before this goes down so much.....plus I dont think they will go down they have been in the 1.5-2 range before....this is good time to buy very very cheap calls....ive got time on it
                  0
                • Call me Caitlyn  this is only down... better get out it will go near  to 0
                  0